SCHEMBL31059664

SCHEMBL31059664

CC(C)(C)n1nc([C@H]2C[C@@H](F)[C@@H](O[Si](C)(C)C(C)(C)C)C2)cc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25348163 1.00 — —
SCHEMBL26039790 1.00 — —
SCHEMBL26039843 0.85 CCNE1 (0.35) —
SCHEMBL26037839 0.85 CYP3A4 (0.31) —
SCHEMBL25349913 0.82 SMN1; SMN2 (0.32) —
SCHEMBL25347799 0.82 SMN1; SMN2 (0.32) —
SCHEMBL25347566 0.80 CCNE1 (0.43) —
SCHEMBL31059760 0.80 CCNE1 (0.43) —
SCHEMBL22286736 0.79 CCNE1 (0.37) —
SCHEMBL31028793 0.79 CCNE1 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240317777-A1 NOVEL MACROCYCLIC AMINOPYRAZOLE COMPOUNDS AS CDK2 INHIBITORS ACCUTAR BIOTECHNOLOGY INC. (US) 2024-09-26 — — US disclosed
WO-2024178335-A2 NOVEL MACROCYCLIC AMINOPYRAZOLE COMPOUNDS AS CDK2 INHIBITORS ACCUTAR BIOTECHNOLOGY, INC. (US) 2024-08-29 — — WO disclosed
Send feedback